Sanofi may appeal French competition body fine
PARIS May 14 (Reuters) - French drugmaker Sanofi said on Tuesday it objected to a fine by the French Competition Authority in a dispute over generic competition to its blood thinner, Plavix, and said it was considering a possible appeal.
The Competition Authority said it fined Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to Plavix. ($1 = 0.7703 euros) (Reporting by Dominique Vidalon; Editing by James Regan)
- South Korea recovers first bodies from inside sunken ferry |
- Special Report: How the U.S. made its Putin problem worse
- Vice-principal of South Korea school in ferry disaster commits suicide |
- Japan expands army footprint for first time in 40 years, risks angering China
- Mediator heads to east Ukraine, seeking surrenders |